Article
Estrogenic activity is increased for an antiestrogen by a natural mutation of the estrogen receptor.
The Journal of steroid biochemistry and molecular biology - 1 Mar 1997
Levenson A S, Catherino W H, Jordan V C
Abstract excerpt
The estrogen receptor (ER) functions as a ligand-activated transcription factor which mediates the actions of estrogens and antiestrogens in target tissues. Other investigators have shown that artificial point mutations in the transcriptional activation domain AF-2 of the ligand binding domain (L...
Topics
- Breast Neoplasms
- Cell Division
- Dose-Response Relationship, Drug
- Estradiol
- Estrogen Antagonists
- Female
- Fulvestrant
- Gene Expression Regulation, Neoplastic
- Humans
- Mutation
- Piperidines
- RNA, Messenger
